Full video transcriptClick to expand
Auto-generated transcript of @coachcam.peps3's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00But more is asking him how I'm able to retain as much information as I'm able to retain,
- 0:03which by the way, thank you very much for dropping the kind compliment. But he's asking, where's the
- 0:06limitless pill at? I'm gonna be teaching you guys about Dijeksa today. If you have not heard about
- 0:10Dijeksa, I'm gonna give you a pretty good overview in this video. We're not gonna be able to talk
- 0:14through literally everything that this compound is doing because it is quite complex. But again,
- 0:17let's do an overview nonetheless. And if you guys have more questions, you can drop in the
- 0:20comment section down below or shoot medium or check out my school where I have an entire deep dive on
- 0:24this compound. But all that out of the way, let's dive into Dijeksa. As always, I'm the nice one,
- 0:28for educational and research purposes, only this is not medical advice. Most of the cognitive
- 0:32compounds that are commonly talked about simple things like caffeine or maybe something like
- 0:35medaphanol or acetam's optimize your current brain's function. Very few of them actually
- 0:40upgrade the infrastructure. That is where Dijeksa comes into the equation. It's not so much of
- 0:45an optimizer as it is an actual infrastructure builder. Think of your brain as essentially a
- 0:49city. All the compounds I previously mentioned, your caffeine's your medaphanol's your acetam's.
- 0:54Those are like traffic optimizers. Okay, they're going to speed up the rate at which cars move,
- 0:59but then as soon as that signal is removed, the cars and the traffic all come back as if nothing
- 1:03changed in the first place. Dijeksa upgrades the entire city. So now instead of having traffic,
- 1:09and then trying to optimize that traffic by making things run quicker, you've effectively built more
- 1:14roads, less traffic, because more roads to travel on. Dijeksa is going to specifically amplify
- 1:19a signaling pathway in the brain known as the HGF or hepatocyte growth factor, C-Met receptor pathway.
- 1:24hepatocyte growth factor is essentially acting as a master construction signal in the body. When
- 1:28it's loud, your neurons are making new connections. When it's quiet, your brain's essentially just in
- 1:32maintenance mode. Dijeksa turns that signal way, way up. In lab studies, it was shown to be 10 million
- 1:39times stronger than brain derived neurotrophic factor, which is largely considered the gold standard
- 1:44for neuroplasticity. Now, whether or not it translates to 10 million times stronger than actual human
- 1:49brain, that's yet to actually be seen. However, the mechanisms are certainly there. Dijeksa does
- 1:56many things in the brain, but there's specifically three different terms that I really think are
- 1:59worth understanding at least in this first overview. The first one is going to be snapogenesis. The
- 2:04second one is going to be dendritic arborization. And the third one is going to be long term
- 2:08potentiation. So we'll break down each three of those. And by the end of this video, you'll have a
- 2:11good understanding of exactly what these mean. The first snapogenesis, this is essentially
- 2:16formation of new synapses. Now, a synapse is an actual physical connection between neurons. So
- 2:21think of neurons as like two communication towers, and the synapses are the roads in between. The
- 2:26more synapses you have, the more connections you have, the more information that could be transferred
- 2:30to and from effectively a better communication for your brain. The next term, dendritic arborization. So
- 2:36each neuron has tentacle-like protrusions that essentially come off of it. And those things are
- 2:40called dendrites. Dendritic arborization is essentially formation of more tentacle protrusions. Now,
- 2:45you have more dendrites that are able to take in more information to communicate from neuron to
- 2:50neuron, again, via those synapses. And we know that dihexas obviously increasing synaptic genesis.
- 2:55So we have more dendrites and more synapses. So more connections are being made and transferring
- 3:00information to and from. And then we have long term potentiation, which is essentially the
- 3:04cellular basis for learning and memory consolidation in the first place. So long term potentiation is
- 3:09not about creating new connections. It's about strengthening the connections that you already
- 3:12have in your brain with repeated use. So for example, let's say you're trying to learn a new
- 3:17language or how to play an instrument, you're trying to learn in depth about peptides because
- 3:21you want to have as much information as you possibly can about these things. That is the repeated use
- 3:25signal. You are constantly firing those synapses towards a specific skill that you're trying to acquire.
- 3:31This is going to essentially upregulate receptors on the neurons. And over time, this is going to make
- 3:35that skill acquisition significantly easier. Essentially with the Compolyte dihexane, again,
- 3:40the benefits go far deeper than what I'm able to do in this strict overview alone,
- 3:44you improve your brain's overall capacity, you improve your brain's ability to acquire new skills
- 3:48to develop new ideas to improve pattern recognition. And you do all this in a much more timely manner
- 3:53as opposed to when you were not on the compound in the first place. The very important part about
- 3:58dihexas is this compound is not selective. And essentially what I mean by that is if you take a
- 4:02compound like dihexane, expect to become smarter, but do nothing to actually become smarter,
- 4:07then you're not going to become smarter. For example, if you deploy dihexa and hopes to develop
- 4:11new connections and new business ideas and become a better human, but you're just doom scrolling on
- 4:16TikTok for 12 hours, you're only going to get better and more efficient at doom scrolling. You're
- 4:20not going to be better at developing a new brand new business model that's going to drive in millions
- 4:24of dollars of revenue. So pair your dihexa with whatever you're trying to optimize. If you want
- 4:28to optimize doom scrolling, then dihexas obviously are a great option for it. But if you're also
- 4:32looking to optimize your business or whatever the heck you're trying to learn, then take dihexa
- 4:36with that window specifically. It is also worth mentioning before our Brown office overview,
- 4:40the HDFC met receptor pathway is a known pathway that can become hijacked by specific tumors. So
- 4:46if you actively have a malignancy or you were not sure that you do, please get with a qualified
- 4:51medical professional prior to starting dihexa. That is it this overview is long again, if you
- 4:56want more information, I have a way longer deep dive like a 30 minute long deep dive in my school
- 5:00community that comes with a complete comprehensive breakdown of this compound and everything that
- 5:04you need to know about it. But that is it for this video. If you guys have any questions,
- 5:07leave the comments section down below or shoot me, DM otherwise, I will see you guys in a future video.
- 5:10Peace.
Dihexa 'unlimited brain capacity': what the science says
Quick answer
Dihexa is an HGF-potentiating peptidomimetic with synaptogenic activity demonstrated in aged rat models (McCoy et al., 2013), but it has no completed human clinical trials and no regulatory approval for any indication. The video accurately names the relevant signaling pathway and neuroplasticity mechanisms, but presents preclinical potency data as if it translates directly to human cognitive enhancement, which has not been established. The safety profile in humans, particularly regarding HGF's role in oncogenesis and hepatocyte proliferation, remains entirely uncharacterized.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Dihexa 'unlimited brain capacity': what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Dihexa 'unlimited brain capacity': what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Dihexa 'unlimited brain capacity': what the science says" from Coach Cam. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Dihexa is an HGF-potentiating peptidomimetic with synaptogenic activity demonstrated in aged rat models (McCoy et al.
The reason this review is not generic is the source wording and the canonical claim label "peptides replying to omar vargas dihexa unlimited brain capacity i go." In this clip, the useful excerpt is: "But more is asking him how I'm able to retain as much information as I'm able to retain, which by the way, thank you very much for dropping the kind compliment." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Emerging pharmacotherapies for obesity: A systematic review (2025), Glucagon-like receptor agonists and next-generation incretin-based medications (2026), and Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Dihexa is an HGF-potentiating peptidomimetic with synaptogenic activity demonstrated in aged rat models (McCoy et al.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Dihexa is an HGF-potentiating peptidomimetic with synaptogenic activity demonstrated in aged rat models (McCoy et al., 2013), but it has no completed human clinical trials and no regulatory approval for any indication. The video accurately names the relevant signaling pathway and neuroplasticity mechanisms, but presents preclinical potency data as if it translates directly to human cognitive enhancement, which has not been established. The safety profile in humans, particularly regarding HGF's role in oncogenesis and hepatocyte proliferation, remains entirely uncharacterized.
- Dihexa has zero completed human clinical trials. All cognitive benefit claims are extrapolated from animal and cell studies.
- The '10 million times stronger than BDNF' figure is an in vitro potency comparison, not a measure of human cognitive outcomes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Dihexa has zero completed human clinical trials. All cognitive benefit claims are extrapolated from animal and cell studies.
- The '10 million times stronger than BDNF' figure is an in vitro potency comparison, not a measure of human cognitive outcomes.
- McCoy et al. (2013, JPET) showed real synaptogenic effects in aged rats, but rat models of cognitive deficit do not reliably predict enhancement in healthy humans.
- HGF/c-Met signaling is implicated in tumor progression and oncogenesis (Organ and Tsao, 2011, Therapeutic Advances in Medical Oncology), meaning the long-term safety profile of Dihexa in humans is genuinely unknown.
- The neurobiological terms in the video (synaptogenesis, dendritic arborization, LTP) are accurately defined, which is more than most peptide content on social media manages.
- Dihexa is not approved by any regulatory agency for human use and is not legally classified as a supplement or pharmaceutical in most jurisdictions.
- Aerobic exercise remains the most evidence-backed intervention for neuroplasticity in humans, with Erickson et al. (2011, PNAS) showing hippocampal volume increases in controlled human trials.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @coachcam.peps3 actually say?
The creator describes Dihexa as a compound that "upgrades the entire city" of your brain, contrasting it with stimulants and nootropics that merely optimize existing function. The core claim is that Dihexa amplifies the HGF/c-Met receptor pathway, driving synaptogenesis, dendritic arborization, and long-term potentiation. He also states it was shown to be "10 million times stronger than brain derived neurotrophic factor" in lab studies, while acknowledging human translation is unproven.
To his credit, he repeatedly frames this as educational content, not medical advice, and qualifies the BDNF comparison by saying whether it "translates to 10 million times stronger than actual human brain, that's yet to actually be seen." That caveat matters. But the video's caption, title, and framing around "unlimited brain capacity" and "the limitless pill" do a lot of work that the caveats don't fully undo.
Does the science back this up?
The mechanism is real. The extrapolation to human cognitive enhancement is not yet supported by evidence. Dihexa (PNB-0408, also N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a small molecule developed at Washington State University that potentiates HGF signaling at the c-Met receptor. McCoy et al. (2013, Journal of Pharmacology and Experimental Therapeutics) demonstrated that Dihexa reversed cognitive deficits in aged rats and showed synaptogenic activity far exceeding BDNF in cell assays.
The "10 million times stronger" figure comes from in vitro potency comparisons, not from measuring cognitive outcomes in living animals, let alone humans. There are no completed human clinical trials on Dihexa as of this writing. The compound has also shown hepatocyte growth factor-driven activity in cancer biology research, which raises questions about long-term safety that are entirely absent from this video. The mechanisms the creator describes, synaptogenesis, dendritic arborization, long-term potentiation, are accurate neurobiological terms and are plausibly connected to HGF/c-Met signaling. The leap from "plausible mechanism in rats" to "infrastructure builder for your brain" is where this video crosses from education into speculation.
What did they get wrong (or right)?
The creator gets the neuroscience vocabulary right. Synaptogenesis, dendritic arborization, and long-term potentiation are accurately defined, and tying them to HGF/c-Met signaling is consistent with the McCoy et al. research. That's more rigor than most peptide content on TikTok manages.
What they get wrong, or at least seriously underplay, is the evidence gap. Saying the BDNF comparison is "yet to be seen" in humans sounds measured, but it glosses over the fact that there is essentially zero human safety data. HGF is a potent mitogen. Compounds that amplify it systemically have potential oncogenic implications, something explored in cancer literature (Organ and Tsao, 2011, Therapeutic Advances in Medical Oncology). The video presents Dihexa as a tool for skill acquisition and pattern recognition with no discussion of who should not use it, what risks exist, or why it hasn't cleared clinical trials. The "limitless pill" framing in the caption is irresponsible regardless of the in-video disclaimers.
- Correct: HGF/c-Met pathway involvement in neuroplasticity
- Correct: Definition and role of synaptogenesis and LTP
- Misleading: Framing preclinical potency as near-human benefit
- Missing: Any mention of safety, oncogenic risk, or regulatory status
What should you actually know?
Dihexa is a research compound with no approved human use, no published human clinical trials, and a mechanism that warrants caution, not enthusiasm. The preclinical data is genuinely interesting. That's not the same as "it works in humans."
The HGF pathway does more than build synapses. It plays roles in liver regeneration, wound healing, and tumor growth. Compounds that potentiate HGF signaling are not simple cognitive supplements. Organ and Tsao (2011) reviewed c-Met pathway dysregulation as a driver of multiple cancers. That doesn't mean Dihexa causes cancer, but it means the risk profile is unknown and the "just try it" culture around unregulated peptides is especially reckless here.
If you're interested in neuroplasticity support, there are interventions with actual human evidence behind them: aerobic exercise (Erickson et al., 2011, PNAS), sleep optimization, and in some contexts, physician-supervised use of compounds with at least Phase II trial data. Dihexa is not in that category. A telehealth provider who recommends it without acknowledging that gap is not practicing evidence-based medicine.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Coach Cam · TikTok creator
9.5K views on this video
Replying to @Omar Vargas Dihexa Unlimited Brain Capacity. I go deeper on this inside the classroom. Checkout my homepage for more content and information! #health #pep #medicine #research #wellness
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about dihexa has zero completed human clinical trials. all cognitive benefit?
Dihexa has zero completed human clinical trials. All cognitive benefit claims are extrapolated from animal and cell studies.
What does the video say about the '10 million times stronger than bdnf' figure?
The '10 million times stronger than BDNF' figure is an in vitro potency comparison, not a measure of human cognitive outcomes.
What does the video say about mccoy et al. (2013, jpet) showed real synaptogenic effects in?
McCoy et al. (2013, JPET) showed real synaptogenic effects in aged rats, but rat models of cognitive deficit do not reliably predict enhancement in healthy humans.
What does the video say about hgf/c-met signaling?
HGF/c-Met signaling is implicated in tumor progression and oncogenesis (Organ and Tsao, 2011, Therapeutic Advances in Medical Oncology), meaning the long-term safety profile of Dihexa in humans is genuinely unknown.
What does the video say about the neurobiological terms in the video (synaptogenesis, dendritic arborization, ltp)?
The neurobiological terms in the video (synaptogenesis, dendritic arborization, LTP) are accurately defined, which is more than most peptide content on social media manages.
What does the video say about dihexa?
Dihexa is not approved by any regulatory agency for human use and is not legally classified as a supplement or pharmaceutical in most jurisdictions.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Coach Cam, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.